Spots Global Cancer Trial Database for phase ib, bhlrm, vob560, mik665, nhl, aml, mm, bcl2, mcl1
Every month we try and update this database with for phase ib, bhlrm, vob560, mik665, nhl, aml, mm, bcl2, mcl1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) | NCT04702425 | Non-Hodgkin Lym... Acute Myeloid L... Multiple Myelom... | VOB560 MIK665 | 18 Years - | Novartis | |
| VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) | NCT04702425 | Non-Hodgkin Lym... Acute Myeloid L... Multiple Myelom... | VOB560 MIK665 | 18 Years - | Novartis | |
| VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) | NCT04702425 | Non-Hodgkin Lym... Acute Myeloid L... Multiple Myelom... | VOB560 MIK665 | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
